Capital Markets | M&A Pharmaceuticals
In what could become Israel’s biggest cross-border M&A deal ever, Teva Pharmaceutical Industries made an unsolicited $40 billion offer to acquire Mylan, a Pennsylvania-based drugmaker registered in the Netherlands with operational headquarters in the UK.
Frontier Markets Report | Myanmar is wide open in terms of investment prospects, and its opportunities are luring investors—despite the risks.
Capital Markets | Debt
Issuance of green bonds, which raise funds to support environmentally beneficial activities, more than tripled last year, to $36 billion, according to the World Bank.
Capital Markets | Mergers & Acquistions
Boutique investment banks are eating the lunch of Wall Street’s bulge-bracket firms.
Capital Markets | Fixed Income
Hungary’s biggest financial scandal, which broke earlier this year, involved the alleged issuance of more than $500 million of phony bonds by Quaestor Financial Hrurira. The brokerage was one of three firms charged with fraud.
Frontier Markets Report | Oman
The sultanate’s proximity to the Gulf has long been an attraction. But with war in neighboring Yemen, its location could be a drawback.